Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Pharmacoeconomics
|
April 10, 2009
Costing and cost analysis in randomized controlled trials: caveat emptor
Daniel Polsky, Henry Glick
Statistics in Medicine
|
June 13, 2003
Assessing the appropriateness of combining economic data from multinational clinical trials
John R Cook, Michael Drummond, Henry Glick, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
February 25, 2011
The effect of telehomecare on heart failure self care
Kathryn H Bowles, Barbara Riegel, Mark G Weiner, et al.
American Journal of Preventive Medicine
|
June 24, 2003
Cholesterol measures to identify and treat individuals at risk for coronary heart disease
Sundar Natarajan, Henry Glick, Michael Criqui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 5, 2021
Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes
Louise Wang, Frank I Scott, Ben Boursi, et al.
Pediatrics
|
November 5, 2003
Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis
Laura N Venditti, Charles P Venditti, Gerard T Berry, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report
Scott D Ramsey, Richard J Willke, Henry Glick, et al.
Psychiatric Services (Washington, D.C.)
|
July 4, 2006
Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs
Mark S Bauer, Linda McBride, William O Williford, et al.
Psychiatric Services (Washington, D.C.)
|
July 4, 2006
Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial
Mark S Bauer, Linda McBride, William O Williford, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 24, 2005
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
Scott Ramsey, Richard Willke, Andrew Briggs, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Pharmacoeconomics
|
April 10, 2009
Costing and cost analysis in randomized controlled trials: caveat emptor
Daniel Polsky, Henry Glick
Statistics in Medicine
|
June 13, 2003
Assessing the appropriateness of combining economic data from multinational clinical trials
John R Cook, Michael Drummond, Henry Glick, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
February 25, 2011
The effect of telehomecare on heart failure self care
Kathryn H Bowles, Barbara Riegel, Mark G Weiner, et al.
American Journal of Preventive Medicine
|
June 24, 2003
Cholesterol measures to identify and treat individuals at risk for coronary heart disease
Sundar Natarajan, Henry Glick, Michael Criqui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 5, 2021
Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes
Louise Wang, Frank I Scott, Ben Boursi, et al.
Pediatrics
|
November 5, 2003
Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis
Laura N Venditti, Charles P Venditti, Gerard T Berry, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report
Scott D Ramsey, Richard J Willke, Henry Glick, et al.
Psychiatric Services (Washington, D.C.)
|
July 4, 2006
Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs
Mark S Bauer, Linda McBride, William O Williford, et al.
Psychiatric Services (Washington, D.C.)
|
July 4, 2006
Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial
Mark S Bauer, Linda McBride, William O Williford, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 24, 2005
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
Scott Ramsey, Richard Willke, Andrew Briggs, et al.
Page
of 2